Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05721859

M-Vizion™ Macroscopic Radiographic Study

Conditions: Revision Hip Arthroplasty

Sex: All
Ages: 21 Years – 80 Years
Enrollment: 70
Sponsor: Medacta USA

Location: United States

Summary

Study of the patient's subsidence after revision hip arthroplasty by assessing gross stem subsidence in the femoral canal.

Eligibility Criteria

Inclusion Criteria:Must be able to read, understand, and provide written informed consent on the Institutional Review Board (IRB) approved Informed Consent Form (ICF).Ability to understand and provide written authorization for use and disclosure of personal health information.Subjects who are able and willing to comply with the study protocol and follow-up visits.Patients requiring a revision total hip replacement.Subjects undergoing revision THA who will receive an M-Vizion femoral component according to the indications for use.Male and female patients ages 21 - 80 years of age at the time of surgery.Exclusion Criteria:Patients with neuromuscular or neurosensory deficiency, which would limit the ability to assess the performance of the device.Patients with a systemic or metabolic disorder leading to progressive bone deterioration.Patients bone stock is compromised by disease or infection, which could possibly prevent adequate support and/or fixation to the prosthesis.Patients with an active or suspected latent infection in or about the hip joint.Patients that are incarcerated.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05721859). StuddyBuddy aggregates publicly available trial information.